About Contact Us Careers

Osteoarthritis Gene Therapy Market Size & Share, by Drug Type {NSAIDs (Aspirin, Diclofenac, Ibuprofen, Naproxen), Corticosteroids, Viscosupplementation Agents, Analgesics (Acetaminophen, Duloxetine)}; Purchasing Pattern (Over-the-Counter, Prescription); Distribution Channel (Hospital, Pharmacies, Online);, End-user (Clinic, Hospital, Nursing Home, Orthopedic) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 4083
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Osteoarthritis Gene Therapy Market size was valued at USD 8.07 billion in 2024 and is likely to cross USD 21.68 billion by 2037, expanding at more than 7.9% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of osteoarthritis gene therapy is estimated at USD 8.61 billion.

The growth of the market can be attributed to the ease of administration, affordable pain medication and therapy, and rising incidents of osteoarthritis diseases across the globe. Moreover, it is believed that 40 to 65% of osteoarthritis includes genetic components. Additionally, significant growth in the geriatric population is also anticipated to influence the growth of the market positively. A study conducted by United Nations (UN) in 2019 stated that 703 million people are aged 65 years or over. Furthermore, a large portion of the global population showed an affirmative response toward gene therapy to treat osteoarthritis disease owing to its high effectiveness. As per a report published by Yale University, a significant surge in patients receiving gene therapy is projected to reach the number of 1.09 million over the forecast period. These factors are anticipated to boost the growth of the global osteoarthritis gene therapy market.

Growth Drivers

  • Rising Cases of Osteoarthritis Among Global Population

  • Low-Cost Medication Available

  • Growing Geriatric Population with Hip and Knee Disorders

Challenges

  • The Consumption of NSAIDs Leading to a High CVD Risk in Patients

Osteoarthritis Gene Therapy Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

7.9%

Base Year Market Size (2024)

USD 8.07 billion

Forecast Year Market Size (2037)

USD 21.68 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Osteoarthritis Gene Therapy Segmentation

The market is segmented by drug type into NSAIDs, corticosteroids, viscosupplementation agents, and analgesics, out of which, the viscosupplementation agent segment is anticipated to hold the largest share in the global osteoarthritis gene therapy market during the forecast period, on account of the high prevalence of knee osteoarthritis in the global population in recent decades. The rising cases of knee osteoarthritis are accounted to the significant change in the lifestyle such as spending more time on PCs resulting in knee joint cartilage wearing out over time. For instance, it was observed that approximately 200 people out of 10,000 suffer from knee osteoarthritis every year globally.

Our in-depth analysis of the global market includes the following segments:

           By Type
  • NSAIDs 
  • Aspirin
  • Diclofenac
  • Ibuprofen
  • Naproxen
  • Corticosteroids
  • Viscosupplementation Agents
  • Analgesics 
    • Acetaminophen
    • Duloxetine

             By Purchasing Pattern
  • Over-the-Counter
  • Prescription

 

 

         By Distribution Channel
  • Hospital
  • Pharmacies
  • Online

            By End-User
  • Clinic
  • Hospital
  • Nursing Home
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Osteoarthritis Gene Therapy Industry - Regional Synopsis

Regionally, the global osteoarthritis gene therapy market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Europe industry is estimated to dominate majority revenue share by 2037, on the back of increasing geriatric population with osteoarthritis disease. Additionally, osteoarthritis is the most common disease among older people, as the joints start to loosen up and get weaker with age. As of 2019, approximately, 90 million people were 65 years old or above in the Europe region. Furthermore, multiple trials of gene therapy are in the process to be modified in the Europe region.

The global osteoarthritis gene therapy market is projected to grow in the North America region, over the forecast period owing to increasing geriatric population with osteoarthritis disease. According to a report by the Administration for Community Living (ACL), in 2019, 54.1 million people in U.S. were aged 65 and over, which was 16% of the population.

Osteoarthritis-Gene-Therapy-Market-Share
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Osteoarthritis Gene Therapy Landscape

    • Sanofi-aventis Groupe
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Horizon Therapeutics plc
    • Hanmi Pharm. Co., Ltd.
    • ALMATICA PHARMA LLC.
    • Assertio Holdings, Inc.
    • Flexion Therapeutic, Inc.
    • Zimmer Biomet Holdings, Inc.
    • Pfizer Inc.
    • Virchow Biotech Privet Limited
    • Bayer AG

Recent Developments

  • April 27, 2022: Horizon Therapeutic plc acquires the fifth rank among top companies for overall corporate reputation in the annual survey of PatientView.

  • April 26, 2022: Sanofi makes the announcement about merging path with McLaren Racing to boost the manufacturing quantity and its excellence standards on a world-class level.

  • Report ID: 4083
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT
  • Explore a preview of key market trends and insights
  • Review sample data tables and segment breakdowns
  • Experience the quality of our visual data representations
  • Evaluate our report structure and research methodology
  • Get a glimpse of competitive landscape analysis
  • Understand how regional forecasts are presented
  • Assess the depth of company profiling and benchmarking
  • Preview how actionable insights can support your strategy

Explore real data and analysis

Download Free Sample Report

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of osteoarthritis gene therapy is estimated at USD 8.61 billion.

Osteoarthritis Gene Therapy Market size was valued at USD 8.07 billion in 2024 and is likely to cross USD 21.68 billion by 2037, expanding at more than 7.9% CAGR during the forecast period i.e., between 2025-2037.

Europe industry is estimated to dominate majority revenue share by 2037, on the back of increasing geriatric population with osteoarthritis disease.

The major players in the market are Sanofi-aventis Groupe, Horizon Therapeutics plc, Hanmi Pharm. Co., Ltd., ALMATICA PHARMA LLC., Assertio Holdings, Inc., Flexion Therapeutic, Inc., Zimmer Biomet Holdings, Inc., Pfizer Inc., and others.

Osteoarthritis Gene Therapy Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos